An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy

OBJECTIVES: Non‐melanoma skin cancers are the most frequently occurring type of cancer worldwide. They can be effectively treated using topical dermatological photodynamic therapy (PDT) employing protoporphyrin IX (PpIX) as the active photosensitising agent as long as the disease remains superficial...

Descripción completa

Detalles Bibliográficos
Autores principales: Anayo, Lizette, Magnussen, Anette, Perry, Alexis, Wood, Mark, Curnow, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032951/
https://www.ncbi.nlm.nih.gov/pubmed/29603761
http://dx.doi.org/10.1002/lsm.22809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032951/
https://www.ncbi.nlm.nih.gov/pubmed/29603761
http://dx.doi.org/10.1002/lsm.22809

Ejemplares similares